TRVI - Wall Street Estimates - Trevi Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 3.91

0.256 %

$ 349 M

Market Cap

-8.89

P/E

Price Target Average

84.14%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

27.14%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Trevi Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for TRVI of $7.2 , with forecasts ranging from a low of $6 to a high of $12 .

TRVI Lowest Price Target Wall Street Target

6 USD 53.45%

TRVI Average Price Target Wall Street Target

7.2 USD 84.14%

TRVI Highest Price Target Wall Street Target

12 USD 206.91%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free